What should otolaryngologists know about dural venous sinus stenting?

Area of Science:

• Otolaryngology
• Neurosurgery
• Neuroradiology

Background:

• Dural venous sinus stenting is an emerging treatment for elevated intracranial pressure (ICP).
• Transverse sinus stenosis is a common cause of increased ICP, presenting with symptoms like headaches and tinnitus.
• Otolaryngologists are often the first point of care for patients with these symptoms.

Purpose of the Study:

• To summarize the clinical and imaging characteristics of patients who can benefit from endovascular sinus stenting.
• To provide an overview of this emerging treatment option for elevated ICP.

Main Methods:

• Review of clinical and imaging data for patients undergoing dural venous sinus stenting.
• Analysis of patient presentation, symptoms, and diagnostic findings.

Main Results:

• Dural venous sinus stenting is now a routine treatment for elevated ICP due to transverse sinus stenosis.
• Previous treatments like diuretics and shunts had limited success and significant risks.
• Alternative surgical methods carried risks of sudden ICP increase, blindness, and death.

Conclusions:

• Endovascular sinus stenting is a viable and increasingly standard treatment for elevated ICP caused by transverse sinus stenosis.
• ENT specialists play a crucial role in identifying patients who may benefit from this procedure.
• This overview aids in selecting appropriate candidates for sinus stenting to manage elevated ICP.